Summary: This commentary urges a paradigm shift in how we approach research and drug development for glioblastoma, reimagining it as an aberrant brain-like organ, distinct from other cancers, to inspire innovative treatment strategies and interdisciplinary collaboration, addressing the minimal progress in extending glioblastoma patient survival despite years of research and investment.

中文翻译：

---

胶质母细胞瘤：不仅仅是另一种癌症

摘要：这篇评论敦促我们对胶质母细胞瘤的研究和药物开发方式进行范式转变，将其重新想象为一种与其他癌症不同的异常类脑器官，以激发创新的治疗策略和跨学科合作，解决在扩展胶质母细胞瘤方面取得的最小进展。尽管经过多年的研究和投资，患者仍然存活。